Journal of Microbiology and Biotechnology

  • 제27권4호
  • /
  • Pages.709-717
  • /
  • 2017
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B5, a Mucosal Adjuvant Derived from a Type II Heat-Labile Enterotoxin of Escherichia coli

  • Lee, Chang Hoon (Bio & Drug Discovery Division, Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology (KRICT)) ;
  • Hajishengallis, George (Department of Microbiology, School of Dental Medicine, The University of Pennsylvania) ;
  • Connell, Terry D. (Department of Microbiology & Immunology and The Witebsky Center for Microbial Pathogenesis and Immunology, The Jacob's School of Medicine and Biomedical Sciences, The University at Buffalo, State University of New York)
  • 투고 : 2016.11.29
  • 심사 : 2017.01.31
  • 발행 : 2017.04.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Mucosal tissues are the initial site through which most pathogens invade. As such, vaccines and adjuvants that modulate mucosal immune functions have emerged as important agents for disease prevention. Herein, we investigated the immunomodulatory mechanisms of the B subunit of Escherichia coli heat-labile enterotoxin type IIa ($LT-IIa-B_5$), a potent non-toxic mucosal adjuvant. Alternations in gene expression in response to $LT-IIa-B_5$ were identified using a genome-wide transcriptional microarray that focused on dendritic cells (DC), a type of cell that broadly orchestrates adaptive and innate immune responses. We found that $LT-IIa-B_5$ enhanced the homing capacity of DC into the lymph nodes and selectively regulated transcription of pro-inflammatory cytokines, chemokines, and cytokine receptors. These data are consistent with a model in which directional activation and differentiation of immune cells by $LT-IIa-B_5$ serve as a critical mechanism whereby this potent adjuvant amplifies mucosal immunity to co-administered antigens.

키워드

참고문헌

  1. Holmgren J, Czerkinsky C. 2005. Mucosal immunity and vaccines. Nat. Med. 11: S45-S53. https://doi.org/10.1038/nm1213
  2. Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, et al. 1998. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur. J. Immunol. 28: 2025-2034. https://doi.org/10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C
  3. van Ginkel FW, Nguyen HH, McGhee JR. 2000. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg. Infect. Dis. 6: 123-132. https://doi.org/10.3201/eid0602.000204
  4. Commins SP. 2015. Mechanisms of oral tolerance. Pediatr. Clin. North Am. 62: 1523-1529. https://doi.org/10.1016/j.pcl.2015.07.013
  5. da Hora VP, Conceicao FR, Dellagostin OA, Doolan DL. 2011. Non-toxic derivatives of LT as potent adjuvants. Vaccine 29: 1538-1544. https://doi.org/10.1016/j.vaccine.2010.11.091
  6. Isaka M, Yasuda Y, Mizokami M, Kozuka S, Taniguchi T, Matano K, et al. 2001. Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine 19: 1460-1466. https://doi.org/10.1016/S0264-410X(00)00348-0
  7. Langridge W, Denes B, Fodor I. 2010. Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Curr. Opin. Investig. Drugs 11: 919-928.
  8. Lee CH, Nawar HF, Mandell L, Liang S, Hajishengallis G, Connell TD. 2010. Enhanced antigen uptake by DCs induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2. Vaccine 28: 3696-3705. https://doi.org/10.1016/j.vaccine.2010.03.016
  9. Boberg A, Gaunitz S, Brave A, Wahren B, Carlin N. 2008. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin. Vaccine 26: 5079-5082. https://doi.org/10.1016/j.vaccine.2008.03.096
  10. Harrod T, Martin M, Russell MW. 2001. Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol. Immunol. 16: 170-177. https://doi.org/10.1034/j.1399-302x.2001.016003170.x
  11. Lee CH, Masso-Welch P, Hajishengallis G, Connell TD. 2011. TLR2-dependent modulation of dendritic cells by $LT-IIa-B_5$, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin. J. Leukoc. Biol. 90: 911-921. https://doi.org/10.1189/jlb.0511236
  12. Murph y KM, Heimberger A B, Loh DY. 1990. Induction by antigen of intrathymic apoptosis of $CD4^+CD8^+TCRlo$ thymocytes in vivo. Science 250: 1720-1723. https://doi.org/10.1126/science.2125367
  13. Saeki H, Moore AM, Brown MJ, Hwang ST. 1999. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature DCs from the skin to regional lymph nodes. J. Immunol. 162: 2472-2475.
  14. Gouwy M, Struyf S, Berghmans N, Vanormelingen C, Schols D, Van Damme J. 2011. CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection. Eur. J. Immunol. 41: 963-973. https://doi.org/10.1002/eji.201041178
  15. Leitner J, Grabmeier-Pfistershammer K, Steinberger P. 2010. Receptors and ligands implicated in human T cell costimulatory processes. Immunol. Lett. 128: 89-97. https://doi.org/10.1016/j.imlet.2009.11.009
  16. Lundgren A, Leach S, Tobias J, Carlin N, Gustafsson B, Jertborn M, et al. 2013. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine 31: 1163-1170. https://doi.org/10.1016/j.vaccine.2012.12.063
  17. Miller T, Fanton M, Nickelson S, Mason H, Webb S. 2012. Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutant Escherichia coli heat-labile toxin in chickens. Avian Pathol. 41: 441-449. https://doi.org/10.1080/03079457.2012.709606
  18. Sun M, He C, Cong Y, Liu Z. 2015. Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol. 8: 969-978. https://doi.org/10.1038/mi.2015.49
  19. Markey KA, Gartlan KH, Kuns RD, MacDonald KP, Hill GR. 2015. Imaging the immunological synapse between DCs and T cells. J. Immunol. Methods 423: 40-44. https://doi.org/10.1016/j.jim.2015.04.029

피인용 문헌

  1. Modulation of antigen presenting cell functions during chronic HPV infection vol.4, pp.None, 2017, https://doi.org/10.1016/j.pvr.2017.08.002
  2. E. coli Enterotoxin LtB Enhances Vaccine-Induced Anti-H. pylori Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions vol.8, pp.9, 2017, https://doi.org/10.3390/cells8090982